Total Funding
22
46
Total FundingPost-IPO Equity raised
Growth Score
-1 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
139353
Verseon’s breakthroughs in computational chemistry, AI, & synthesis create novel pharmaceuticals. Atom by atom, we drive innovation.
- Adityo Prakash: CEO
- Eniko Fodor: COO
About the Company
Verseon is a technology-based pharmaceutical company developing novel therapeutics for today’s challenging diseases. The company’s proprietary drug discovery platform is the first systematic, computationally-driven solution to achieve the molecular modeling accuracy necessary for rapid and cost-effective drug discovery.
Verseon plans to use its
platform to establish a diversified discovery pipeline across multiple disease areas. It was founded in 2002 and is headquartered in Fremont, California.
Women Founded
